311 related articles for article (PubMed ID: 27106810)
1. Gender Differences in Antihypertensive Treatment: Myths or Legends?
Muiesan ML; Salvetti M; Rosei CA; Paini A
High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):105-13. PubMed ID: 27106810
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
Gu Q; Burt VL; Paulose-Ram R; Dillon CF
Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
[TBL] [Abstract][Full Text] [Related]
3. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
4. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
5. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11.
Neuhauser HK; Adler C; Rosario AS; Diederichs C; Ellert U
J Hum Hypertens; 2015 Apr; 29(4):247-53. PubMed ID: 25273858
[TBL] [Abstract][Full Text] [Related]
6. The Role of Beta-Blockers in the Treatment of Hypertension.
Cruickshank JM
Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
[TBL] [Abstract][Full Text] [Related]
7. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
8. Treating essential hypertension. The first choice is usually a thiazide diuretic.
Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
[TBL] [Abstract][Full Text] [Related]
9. Challenges in the Management of Hypertension in Older Populations.
Pont L; Alhawassi T
Adv Exp Med Biol; 2017; 956():167-180. PubMed ID: 27815929
[TBL] [Abstract][Full Text] [Related]
10. The persisting gender gap in hypertension management and control in Germany: 1998 and 2008-2011.
Sarganas G; Neuhauser HK
Hypertens Res; 2016 Jun; 39(6):457-66. PubMed ID: 26818655
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?
Sindone A; Erlich J; Lee C; Newman H; Suranyi M; Roger SD
Intern Med J; 2016 Mar; 46(3):364-72. PubMed ID: 26968600
[TBL] [Abstract][Full Text] [Related]
13. Gender-related differences in the management of hypertension by cardiologists: the PARITE study.
Mounier-Vehier C; Simon T; Guedj-Meynier D; Ferrini M; Ghannad E; Hubermann JP; Jullien G; Poncelet P; Achouba A; Quéré S; Guenoun M
Arch Cardiovasc Dis; 2012 May; 105(5):271-80. PubMed ID: 22709468
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and Pharmacological Therapy in Women.
Lodi E; Carollo A; Martinotti V; Modena MG
High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):147-150. PubMed ID: 29623553
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
Petrella R; Michailidis P
Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
[TBL] [Abstract][Full Text] [Related]
17. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
18. Treating hypertension in women: open-ended questions and therapeutic options.
Morganti A
J Hypertens Suppl; 2002 May; 20(2):S44-6. PubMed ID: 12183851
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective.
Thoenes M; Neuberger HR; Volpe M; Khan BV; Kirch W; Böhm M
J Hum Hypertens; 2010 May; 24(5):336-44. PubMed ID: 19798089
[TBL] [Abstract][Full Text] [Related]
20. A critical appraisal of the guidelines from France, the UK, Europe and the USA for the management of hypertension in adults.
Stephan D; Gaertner S; Cordeanu EM
Arch Cardiovasc Dis; 2015; 108(8-9):453-9. PubMed ID: 26113481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
